↓ Skip to main content

Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana

Overview of attention for article published in Malaria Journal, November 2012
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
80 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana
Published in
Malaria Journal, November 2012
DOI 10.1186/1475-2875-11-388
Pubmed ID
Authors

Benjamin Abuaku, Nancy Duah, Lydia Quaye, Neils Quashie, Kwadwo Koram

Abstract

In 2008, artemether - lumefantrine (AL) and dihydroartemisinin - piperaquine (DHAP) were added to artesunate - amodiaquine (AS-AQ) as first-line drugs for uncomplicated malaria in Ghana. The introduction of new drugs calls for continuous monitoring of these drugs to provide timely information on trends of their efficacy and safety to enhance timely evidence-based decision making by the National Malaria Control Programme. In this regard, the therapeutic efficacy of AL was monitored from September 2010 to April 2011 in four sentinel sites representing the three main ecological zones of the country.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Switzerland 1 1%
Tanzania, United Republic of 1 1%
Vietnam 1 1%
United Kingdom 1 1%
Belgium 1 1%
Spain 1 1%
Unknown 74 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 21%
Student > Ph. D. Student 10 13%
Student > Bachelor 8 10%
Student > Master 7 9%
Student > Doctoral Student 7 9%
Other 21 26%
Unknown 10 13%
Readers by discipline Count As %
Medicine and Dentistry 18 23%
Agricultural and Biological Sciences 15 19%
Biochemistry, Genetics and Molecular Biology 7 9%
Social Sciences 6 8%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Other 17 21%
Unknown 13 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 November 2012.
All research outputs
#2,902,807
of 3,628,651 outputs
Outputs from Malaria Journal
#1,089
of 1,320 outputs
Outputs of similar age
#219,273
of 275,205 outputs
Outputs of similar age from Malaria Journal
#65
of 86 outputs
Altmetric has tracked 3,628,651 research outputs across all sources so far. This one is in the 2nd percentile – i.e., 2% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,320 research outputs from this source. They receive a mean Attention Score of 3.5. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 275,205 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 86 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.